These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1169 related articles for article (PubMed ID: 23180662)
1. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells. Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662 [TBL] [Abstract][Full Text] [Related]
2. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253 [TBL] [Abstract][Full Text] [Related]
4. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent. Shameli A; Clemente-Casares X; Wang J; Santamaria P J Immunol; 2011 Sep; 187(6):2859-66. PubMed ID: 21824864 [TBL] [Abstract][Full Text] [Related]
5. CD4+ Foxp3+ regulatory T cells mediate Toxoplasma gondii-induced T-cell suppression through an IL-2-related mechanism but independently of IL-10. Tenorio EP; Fernández J; Castellanos C; Olguín JE; Saavedra R Eur J Immunol; 2011 Dec; 41(12):3529-41. PubMed ID: 21905022 [TBL] [Abstract][Full Text] [Related]
6. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules. Shen X; Niu C; König R Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721 [TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738 [TBL] [Abstract][Full Text] [Related]
8. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation. Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555 [TBL] [Abstract][Full Text] [Related]
10. Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines. Xie D; Hai B; Xie X; Liu L; Ayello J; Ma X; Zhang J Cell Immunol; 2009; 259(2):157-64. PubMed ID: 19616200 [TBL] [Abstract][Full Text] [Related]
11. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells. Raffin C; Raimbaud I; Valmori D; Ayyoub M J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454 [TBL] [Abstract][Full Text] [Related]
12. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis. Coleman MM; Finlay CM; Moran B; Keane J; Dunne PJ; Mills KH FEMS Immunol Med Microbiol; 2012 Apr; 64(3):413-24. PubMed ID: 22211712 [TBL] [Abstract][Full Text] [Related]
13. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169 [TBL] [Abstract][Full Text] [Related]
14. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204 [TBL] [Abstract][Full Text] [Related]
15. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210 [TBL] [Abstract][Full Text] [Related]
16. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Winger EE; Reed JL Am J Reprod Immunol; 2011 Oct; 66(4):320-8. PubMed ID: 21314851 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956 [TBL] [Abstract][Full Text] [Related]
18. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982 [TBL] [Abstract][Full Text] [Related]
19. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865 [TBL] [Abstract][Full Text] [Related]
20. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]